OSOmid Shirvani

Omid Shirvani

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Omid Shirvani has a total of 99 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Functional outcomes and quality of life after endovascular thrombectomy in large and extensive infarcts (ASPECTS 0–5): a multicentre registry study

    by Hannah Asperger, Felix J Bode, Taraneh Ebrahimi, Lara Klehr, Julia Layer, Julius Meißner, Louisa Nitsch, Omid Shirvani, Christian S Thielscher, Niklas M von Danwitz, et al.

    Introduction: Endovascular thrombectomy (EVT) is established for large infarcts, but remains cautiously applied in extensive infarcts with an Alberta Stroke Program Early CT Score (ASPECTS) of 0–2. Real-life outcome data remain limited. Patients and methods: Retrospective analysis of the German Stroke Registry-Endovascular Treatment comparing extensive (ASPECTS 0–2) and large infarcts (ASPECTS 3–5) in patients with anterior-circulation occlusion and EVT. The primary outcome was the ordinal 90-day mRS distribution; secondary outcomes were mRS 0–3, survival, quality of life (3-level European Quality of Life-5 Dimensions) and living condition. Results: Of 18,069 screened patients, 889 were analysed (ASPECTS 1–2, n = 89; ASPECTS 3–5, n = 800); none had ASPECTS 0. With ASPECTS 1–2, 20.2% achieved mRS 0–3 and 55.1% died within 90 days. In the model including successful reperfusion, no statistically significant association was detected between infarct group and the 90-day mRS distribution (common odds ratio [cOR] 0.80; 95% CI, 0.53–1.23) or mRS 0–3 (adjusted odds ratio [aOR] 0.89; 95% CI, 0.64–1.25), whereas successful reperfusion was associated with both (cOR 3.68; 95% CI, 2.31–5.85 and aOR 4.10; 95% CI, 2.45–6.86). Among survivors, median European Quality of Life-5 Dimensions utility index was 0.445 vs 0.541 (n = 27/324), and 51.5% vs 50.9% lived at home (n = 33/411). Discussion: An extensive infarct carried a challenging prognosis, yet acceptable outcome and non-institutional living remained achievable in a relevant minority. An independent association of infarct group with outcome was not detected. Conclusion: An acceptable outcome remained attainable in selected patients with extensive infarction, particularly after successful reperfusion. Lacking a medically managed comparator, these data describe prognosis rather than treatment effect.

  • Real-World Validation of the HERMES-24 Score for Outcome Prediction After Large Vessel Occlusion Treatment in Late Time Window Patients

    by Omid Shirvani, Felix J. Bode, Sebastian Stösser, Hannah Asperger, Taraneh Ebrahimi, Lara Klehr, Julia Layer, Julius Meissner, Svenja Odensass, Anna Skobel, et al.

    ObjectivesThe HERMES-24 score recently demonstrated high accuracy for outcome prediction after large vessel occlusion (LVO) treatment in late time window patients from randomized clinical trials. I...

  • Open Access

    Impact of Severe Prestroke Disability on Outcomes After Mechanical Thrombectomy: A Multicenter Analysis

    by Hannah Asperger, Felix Bode, Taraneh Ebrahimi, Christine Kindler, Julia Layer, Julius Nicolai Meißner, Louisa Nitsch, Omid Shirvani, Christian Thielscher, Niklas Michael von Danwitz, et al.

    BACKGROUND: Patients with severe prestroke disability (PSD) remain underrepresented in mechanical thrombectomy studies, despite their growing relevance in aging populations. This study used data from the German Stroke Registry-Endovascular Treatment to evaluate functional recovery, mortality, and poststroke care outcomes in this high-risk population. METHODS: We analyzed 9456 mechanical thrombectomy–treated patients with stroke from the German Stroke Registry-Endovascular Treatment (2015–2021), categorized by premorbid modified Rankin Scale (mRS): no PSD (mRS score, 0–1), moderate PSD (mPSD; mRS score, 2–3), and severe PSD (sPSD; mRS score, 4–5). Favorable outcomes were defined as an mRS score of 0 to 2 or return to baseline. Logistic regression adjusted for age, National Institutes of Health Stroke Scale, intravenous thrombolysis, reperfusion success, and sex was used to predict outcomes. A neural network subsequently explored feature importance. RESULTS: Among 9456 patients, 7387 had no PSD, 1648 mPSD, and 421 sPSD. Unadjusted 90-day outcomes showed increasing mortality with PSD severity and fewer favorable outcomes in both PSD groups. At 90 days, favorable outcomes occurred in 3020 patients without PSD (40.9%), 232 with mPSD (14.1%), and 85 with sPSD (20.2%). After adjustment, only mPSD was associated with lower odds of favorable outcomes, while both mPSD and sPSD remained independent predictors of higher mortality. Complication rates were similar across groups, except for higher vasospasm in patients without PSD. Including rebalanced sPSD samples in predictive models resulted in minor performance improvements but notable shifts in feature importance, with age and Alberta Stroke Program Early Computed Tomography Score emerging as key predictors, National Institutes of Health Stroke Scale decreasing in relevance, and factors such as local anesthesia and occlusion location becoming more prominent. CONCLUSIONS: Despite higher mortality, approximately a fifth of patients with PSD achieved favorable outcomes, suggesting that this group should not be routinely excluded from mechanical thrombectomy. Further studies should refine patient selection criteria and outcome definitions for this vulnerable population. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT03356392.

  • Portable ultra-low-field MRI in acute stroke care: A pilot study

    by Niklas M von Danwitz, Nils C Lehnen, Julius N Meißner, Omid Shirvani Samani, Hannah Asperger, Christian Thielscher, Taraneh Ebrahimi, Julia Layer, Louisa Nitsch, Franziska Dorn, et al.

    Introduction: Neuroimaging is a prerequisite for treatment of stroke patients, but it is not available all over the globe. Portable ultra-low field (pULF) MRI has the potential to improve access to neuroimaging and thus stroke care worldwide. In a pilot study, we were the first to utilise pULF-MRI in a European tertiary stroke centre and to evaluate its diagnostic value compared to high-field (HF) MRI. Patients and methods: Consecutive patients admitted for suspected ischaemic stroke underwent pULF-MRI using the 0.064 Tesla Swoop® portable MR imaging system in addition to standard imaging. HF-MRI and pULF-MRI scans were blindly assessed to compare the diagnostic accuracy and imaging-based therapeutic decisions based on pULF-MRI to HF-MRI. Results: Seventeen patients underwent pULF-MRI, 12 of whom had ischaemic lesions on HF-MRI. Ischaemic lesions were detected on pULF-MRI in 8/12 cases. The four infarcts not identified on pULF-MRI were all smaller than 6 mm in diameter. In all cases, a virtual treatment decision based on pULF-MRI by a blinded team matched the actual clinical decisions. Conclusion: This single-centre study demonstrates that pULF-MRI is a promising tool in acute stroke care, providing reliable imaging for treatment decision and follow-up monitoring. pULF-MRI may support acute stroke care if HF-MRI is unavailable and may be particularly helpful in resource-limited settings. Limitations of pULF-MRI include long acquisition times and the lack of vessel imaging and haemorrhage-sensitive sequences.


  • Patterns and predictors of delayed functional independence and dependence after thrombectomy in large vessel occlusion stroke: A multicenter analysis

    by Niklas M von Danwitz, Felix J Bode, Omid Shirvani Samani, Hannah Asperger, Taraneh Ebrahimi, Johannes Kaesmacher, Julia Layer, Nils Lehnen, Louisa Nitsch, Julius N Meissner, et al.

    Introduction: Predicting functional outcomes following endovascular treatment (EVT) for large-vessel occlusion stroke (LVOS) is challenging. Some patients achieve functional independence (modified Rankin Scale (mRS) 0 -2) at 90 days despite being dependent at discharge, termed delayed functional independence (DFI), while others lose independence after discharge, termed delayed functional dependence (DFD). This study explores patterns and predictors of DFI and DFD in LVOS patients undergoing EVT. Patients and methods: We analyzed anterior circulation LVOS patients from the prospective multicenter German Stroke Registry. Multivariable logistic regression models identified independent predictors of DFI and DFD. Results: Of 5909 patients, 2346 were independent at discharge, with 16.1% experiencing DFD at 90 days. DFD was associated with older age (median 78 vs 69 years, p < 0.001), female sex (61.4% vs 46.1%, p < 0.001), and greater stroke severity. Variables associated with DFD in multivariable analysis included older age, female sex, higher premorbid and discharge mRS, higher NIHSS at discharge, and absence of IV thrombolysis. Of 3563 patients dependent at discharge, 20.6% achieved DFI. DFI patients were younger (median 71 vs 77 years, p < 0.001), less likely female (38.7% vs 52.6%, p < 0.001) and had lower admission NIHSS, better pre-stroke functional status, higher ASPECTS and more frequent successful recanalization. Variables associated with DFI in multivariable analysis included younger age, male sex, better pre-stroke functional status, lower stroke severity and successful recanalization. Discussion and conclusion: Both DFD and DFI are frequent in clinical practice, with higher DFD and lower DFI rates in women, which warrants further investigation. Understanding these predictors can enhance individualized patient counseling and management strategies.

  • Open Access

    Correction: Validity of the test for attentional performance in neurological post-COVID condition

    by Susan Seibert, Irina Eckert, Catherine N. Widmann, Taraneh Ebrahimi, Fabian Bösl, Christiana Franke, Harald Prüss, Joachim L. Schultze, Gabor C. Petzold, Omid Shirvani


  • Open Access

    Validity of the test for attentional performance in neurological post-COVID condition

    by Susan Seibert, Irina Eckert, Catherine N. Widmann, Taraneh Ebrahimi, Fabian Bösl, Christiana Franke, Harald Prüss, Joachim L. Schultze, Gabor C. Petzold, Omid Shirvani

    Neurological post-COVID condition (PCC) often involves attentional deficits that impact daily functioning. Traditional paper-based tests, like the Trail-Making Test (TMT), may inadequately capture these impairments due to their short duration and dependence on numerical and alphabetic sequencing. This study evaluates the validity of three subtests of the computerized Test for Attentional Performance (TAP) as alternatives for detecting attentional impairments in PCC. In the ongoing NEURO LC-19 DE study, 108 subjects aged 18 to 79 years, with PCC-related cognitive complaints (n = 67, 73% f) and healthy controls (n = 41, 56% f) underwent neuropsychological testing. The prevalence of impairment and classification ability of the TAP subtests were evaluated alongside standard paper-based tests, including the TMT and Montreal Cognitive Assessment, using receiver operating characteristic (ROC) analysis and regression. The TAP subtests identified significant impairments in sustained attention and processing speed in one-third of PCC patients, surpassing traditional tests in sensitivity, and classifying PCC with an AUC of 78%. Omissions in sustained attention significantly differentiated groups (OR = 1.14, p = 0.016, 95% CI [1.02–1.26]). Fatigue correlated with poorer performance on speed and accuracy (r > 0.30, p < 0.05). Cognitive slowing is prevalent in neurological PCC but is scarcely captured by conventional assessments. The TAP’s computerized format with automated norming and independence from alphanumeric stimuli shows promise in improving the discriminatory ability for identifying attentional deficits in PCC patients.


  • Home and workforce reintegration one year after thrombectomy in acute stroke patients

    by Felix J Bode, Nina A Zadon, Hannah Asperger, Niklas M Beckonert, Taraneh Ebrahimi, Louisa Nitsch, Julia Nordsiek, Julius N Meissner, Omid Shirvani, Sebastian Stösser, et al.

    Introduction: Endovascular thrombectomy (EVT) combined with intravenous thrombolysis is the current standard treatment for acute large-vessel occlusion stroke. Beyond clear clinical benefits in the acute and post-acute phases, comprehensive evaluations of long-term outcomes, including home and workforce reintegration, remain limited. This study aimed to assess home and workforce reintegration 1 year post-EVT in a cohort of acute stroke patients and explore their association with health-related quality of life (HRQoL). Patients and methods: We conducted a prospective observational study of 404 patients undergoing EVT at a tertiary university medical center between October 2019 and December 2021. Patients’ functional outcomes were evaluated using the modified Rankin Scale (mRS), and HRQoL was assessed via the European Quality of Life Five Dimension Scale (EQ-5D). Data on occupational and living status were collected through standardized telephone interviews at 3- and 12-months post-treatment. Results: Of 357 patients with 12-month follow-up data, 33.6% had a favorable outcome (mRS 0–2). Among stroke survivors, the rate of home reintegration without nursing care was 42.1%, and workforce reintegration among previously employed patients was 43.3% at 12 months. Both outcomes were significantly associated with improved HRQoL. Lower neurological deficits and younger age were predictive of successful home and workforce reintegration. Discussion and conclusion: One year post-EVT, approximately 40%–50% of acute stroke patients successfully reintegrate into home and work settings. These findings underscore the need for ongoing support tailored to improving long-term reintegration and quality of life for stroke survivors. Data access statement: The data supporting the findings of the study are available from the corresponding author upon reasonable request and in accordance to European data privacy obligations.


  • Open Access

    Aetiology of Acute Respiratory Insufficiency in Patients With Ischaemic Stroke Studied by Chest CT Scan

    by Omid Shirvani, Patricia Fischbein, Zeynep Bendella, Piergiorgio Profico, Franziska Dorn, Gabor C. Petzold, Sebastian Stösser

    Background: Acute respiratory insufficiency (ARI) is considered a serious life‐threatening complication after ischaemic stroke. The aim of this study was to identify the most common aetiologies of ARI after stroke and their association with patients' outcome.Methods: This retrospective study was conducted at the University Hospital Bonn, involving patients with acute ischaemic stroke who underwent chest CT scans for ARI between 2017 and 2022. We collected clinical and demographic data, laboratory parameters, vital signs, as well as outcome parameters. CT scans were reviewed by a radiologist. The dataset was analysed to identify the most frequent aetiologies and their associations to outcome parameters.Results: We included 236 patients with a median age of 75 years and a median NIHSS score of 11. In‐hospital mortality accounted for 30.5%. The most frequent pulmonary conditions on CT, in order of prevalence, included bronchitis/bronchiolitis (66.1%), atelectasis (66.1%), pleural effusion (60.6%), pneumonia (53%), pulmonary oedema (37.3%), and pulmonary artery embolism (27.5%). Bronchitis/bronchiolitis was an independent risk factor for mortality (OR = 3.17, 95% CI: 1.11–8.79, p = 0.03). A higher number of pulmonary conditions decreased the likelihood of discharge to home, and non‐survivors had worse vital/laboratory parameters.Conclusions: We identified six key pulmonary aetiologies of ARI after ischaemic stroke, with bronchitis/bronchiolitis notably linked to in‐hospital mortality in our study cohort. An increased number of these acute pulmonary conditions decreased the likelihood of discharge to home. Early chest CT/CT‐angiography may help to identify patients at high risk for in‐hospital mortality and to initiate appropriate treatment early.


  • Open Access

    Machine learning models for outcome prediction in thrombectomy for large anterior vessel occlusion

    by Omid Shirvani, Stefanie Warnat‐Herresthal, Ivan Savchuk, Felix J. Bode, Louisa Nitsch, Sebastian Stösser, Taraneh Ebrahimi, Niklas von Danwitz, Hannah Asperger, Julia Layer, et al.

    Objective: Predicting long‐term functional outcomes shortly after a stroke is challenging, even for experienced neurologists. Therefore, we aimed to evaluate multiple machine learning models and the importance of clinical/radiological parameters to develop a model that balances minimal input data with reliable predictions of long‐term functional independency.Methods: Our study utilized data from the German Stroke Registry on patients with large anterior vessel occlusion who underwent endovascular treatment. We trained seven machine learning models using 30 parameters from the first day postadmission to predict a modified Ranking Scale of 0–2 at 90 days poststroke. Model performance was assessed using a 20‐fold cross‐validation and one‐sided Wilcoxon rank‐sum tests. Key features were identified through backward feature selection.Results: We included 7485 individuals with a median age of 75 years and a median NIHSS score at admission of 14 in our analysis. Our Deep Neural Network model demonstrated the best performance among all models including data from 24 h postadmission. Backward feature selection identified the seven most important features to be NIHSS after 24 h, age, modified Ranking Scale after 24 h, premorbid modified Ranking Scale, intracranial hemorrhage within 24 h, intravenous thrombolysis, and NIHSS at admission. Narrowing the Deep Neural Network model's input data to these features preserved the high performance with an AUC of 0.9 (CI: 0.89–0.91).Interpretation: Our Deep Neural Network model, trained on over 7000 patients, predicts 90‐day functional independence using only seven clinical/radiological features from the first day postadmission, demonstrating both high accuracy and practicality for clinical implementation on stroke units.